118 related articles for article (PubMed ID: 26874236)
1. Multiplex bead-based immunoassay for the free soluble forms of the HLA-G receptors, ILT2 and ILT4.
Wu CL; Svendsen SG; Riviere A; Desgrandchamps F; Carosella ED; LeMaoult J
Hum Immunol; 2016 Sep; 77(9):720-6. PubMed ID: 26874236
[TBL] [Abstract][Full Text] [Related]
2. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
[TBL] [Abstract][Full Text] [Related]
3. HLA-G and HLA-E in patients with juvenile idiopathic arthritis.
Prigione I; Penco F; Martini A; Gattorno M; Pistoia V; Morandi F
Rheumatology (Oxford); 2011 May; 50(5):966-72. PubMed ID: 21186170
[TBL] [Abstract][Full Text] [Related]
4. The role of soluble HLA-G and HLA-G receptors in patients with hematological malignancies after allogeneic stem cell transplantation.
Biedroń M; Rybka J; Wróbel T; Prajs I; Poręba R; Kuliczkowski K
Med Oncol; 2015 Aug; 32(8):219. PubMed ID: 26187179
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors.
Lepin EJ; Bastin JM; Allan DS; Roncador G; Braud VM; Mason DY; van der Merwe PA; McMichael AJ; Bell JI; Powis SH; O'Callaghan CA
Eur J Immunol; 2000 Dec; 30(12):3552-61. PubMed ID: 11169396
[TBL] [Abstract][Full Text] [Related]
6. Decidual macrophages are potentially susceptible to inhibition by class Ia and class Ib HLA molecules.
Petroff MG; Sedlmayr P; Azzola D; Hunt JS
J Reprod Immunol; 2002; 56(1-2):3-17. PubMed ID: 12106880
[TBL] [Abstract][Full Text] [Related]
7. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.
LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED
FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976
[TBL] [Abstract][Full Text] [Related]
8. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.
Huang J; Burke P; Yang Y; Seiss K; Beamon J; Cung T; Toth I; Pereyra F; Lichterfeld M; Yu XG
J Virol; 2010 Oct; 84(20):10784-91. PubMed ID: 20702625
[TBL] [Abstract][Full Text] [Related]
9. The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma.
García M; Palma MB; Verine J; Miriuka S; Inda AM; Errecalde AL; Desgrandchamps F; Carosella ED; Tronik-Le Roux D
BMC Cancer; 2020 Jul; 20(1):624. PubMed ID: 32620162
[TBL] [Abstract][Full Text] [Related]
10. ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct Mechanisms.
Tian J; Ashique AM; Weeks S; Lan T; Yang H; Chen HH; Song C; Koyano K; Mondal K; Tsai D; Cheung I; Moshrefi M; Kekatpure A; Fan B; Li B; Qurashi S; Rocha L; Aguayo J; Rodgers C; Meza M; Heeke D; Medfisch SM; Chu C; Starck S; Basak NP; Sankaran S; Malhotra M; Crawley S; Tran TT; Duey DY; Ho C; Mikaelian I; Liu W; Rivera LB; Huang J; Paavola KJ; O'Hollaren K; Blum LK; Lin VY; Chen P; Iyer A; He S; Roda JM; Wang Y; Sissons J; Kutach AK; Kaplan DD; Stone GW
Cancer Immunol Res; 2024 May; 12(5):592-613. PubMed ID: 38393969
[TBL] [Abstract][Full Text] [Related]
11. Analysis of immunoglobulin-like transcripts (ILTs) in lymphocytes with sHLA-G and IL10 from SLE patients.
Chen J; Shen B; Jiang Y; Jun L; Zhu M; Chen B; Liu C
Clin Exp Med; 2013 May; 13(2):135-42. PubMed ID: 22562117
[TBL] [Abstract][Full Text] [Related]
12. HLA-G1, but Not HLA-G3, Suppresses Human Monocyte/Macrophage-mediated Swine Endothelial Cell Lysis.
Eguchi H; Maeda A; Lo PC; Matsuura R; Esquivel EL; Asada M; Sakai R; Nakahata K; Yamamichi T; Umeda S; Deguchi K; Ueno T; Okuyama H; Miyagawa S
Transplant Proc; 2016 May; 48(4):1285-7. PubMed ID: 27320605
[TBL] [Abstract][Full Text] [Related]
13. Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.
Wu D; Kuiaste I; Moreau P; Carosella E; Yotnda P
Oncotarget; 2015 Nov; 6(35):37385-97. PubMed ID: 26460949
[TBL] [Abstract][Full Text] [Related]
14. Structural Modeling and Molecular Dynamics of the Immune Checkpoint Molecule HLA-G.
Arns T; Antunes DA; Abella JR; Rigo MM; Kavraki LE; Giuliatti S; Donadi EA
Front Immunol; 2020; 11():575076. PubMed ID: 33240264
[TBL] [Abstract][Full Text] [Related]
15. Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1.
McIntire RH; Morales PJ; Petroff MG; Colonna M; Hunt JS
J Leukoc Biol; 2004 Dec; 76(6):1220-8. PubMed ID: 15459235
[TBL] [Abstract][Full Text] [Related]
16. Cytometry-based analysis of HLA-G functions according to ILT2 expression.
Jacquier A; Dumont C; Carosella ED; Rouas-Freiss N; LeMaoult J
Hum Immunol; 2020 Apr; 81(4):168-177. PubMed ID: 32081570
[TBL] [Abstract][Full Text] [Related]
17. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
Zhang W; Liang S; Wu J; Horuzsko A
Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
[TBL] [Abstract][Full Text] [Related]
18. HLA-G promotes myeloid-derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4.
Köstlin N; Ostermeir AL; Spring B; Schwarz J; Marmé A; Walter CB; Poets CF; Gille C
Eur J Immunol; 2017 Feb; 47(2):374-384. PubMed ID: 27859042
[TBL] [Abstract][Full Text] [Related]
19. HLA-G-ILT2 interaction contributes to suppression of bone marrow B cell proliferation in acquired aplastic anemia.
Sun YX; Feng Q; Wang SW; Li X; Sheng Z; Peng J
Ann Hematol; 2022 Apr; 101(4):739-748. PubMed ID: 35041051
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling.
Zhang Y; Zhao J; Qiu L; Zhang P; Li J; Yang D; Wei X; Han Y; Nie S; Sun Y
Tumour Biol; 2016 Aug; 37(8):11187-98. PubMed ID: 26939901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
